Cipher Pharmaceuticals's market cap is currently $323.70M. The company's EPS TTM is C$0.896; its P/E ratio is 13.94; Cipher Pharmaceuticals is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is C$0.27. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 21.16M	$ 20.68M	$ 21.94M	$ 21.61M	$ 22.45M
Gross Profit	$ 17.09M	$ 16.68M	$ 18.26M	$ 18.55M	$ 19.55M
Operating Income	$ 11.53M	$ 11.09M	$ 11.82M	$ 12.20M	$ 11.68M
EBITDA	$ 11.26M	$ 11.95M	$ 13.66M	$ 13.40M	$ 12.87M
Net Income	$ 20.38M	$ 26.64M	$ 7.76M	$ 4.55M	$ 3.24M
Balance Sheet
Cash & Short-Term Investments	$ 39.83M	$ 28.84M	$ 20.55M	$ 9.14M	$ 6.35M
Total Assets	$ 86.03M	$ 73.78M	$ 51.65M	$ 44.28M	$ 46.45M
Total Debt	$ 353.00K	$ 428.00K	$ 516.00K	$ 1.85M	$ 9.57M
Net Debt	$ -39.47M	$ -28.41M	$ -20.03M	$ -7.29M	$ 3.22M
Total Liabilities	$ 5.51M	$ 9.70M	$ 12.75M	$ 11.63M	$ 18.44M
Stockholders' Equity	$ 80.52M	$ 64.08M	$ 38.90M	$ 32.64M	$ 28.01M
Cash Flow
Free Cash Flow	$ 15.86M	$ 10.49M	$ 13.81M	$ 10.93M	$ 7.55M
Operating Cash Flow	$ 16.00M	$ 10.57M	$ 13.81M	$ 11.69M	$ 8.86M
Investing Cash Flow	$ -144.00K	$ -81.00K	$ 0.00	$ -760.00K	$ -1.46M
Financing Cash Flow	$ -5.24M	$ -1.91M	$ -2.47M	$ -8.13M	$ -10.53M

Currency in USD

Cipher Pharmaceuticals Earnings and Revenue History

Income Statement >

Cipher Pharmaceuticals Debt to Assets

Balance Sheet >

Cipher Pharmaceuticals Cash Flow

Cash Flow >

Cipher Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing